Dopamine Hydrochloride Injection shortage
Current 11 presentations · 3 manufacturers · first FDA posting Nov 6, 2017 · last update Oct 14, 2026
Manufacturers: Baxter Healthcare, Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company
Stated reasons (per FDA): Demand increase for the drug; Other
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02) | Baxter Healthcare | Current Available |
— | Posted Nov 6, 2017 Updated Oct 2, 2026 | |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03) | Baxter Healthcare | Current Available |
— | Posted Nov 6, 2017 Updated Oct 2, 2026 | |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02) | Baxter Healthcare | Current Available |
— | Posted Nov 6, 2017 Updated Oct 2, 2026 | |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03) | Baxter Healthcare | Current Available |
— | Posted Nov 6, 2017 Updated Oct 2, 2026 | |
| Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9252-25) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Demand increase for the drug | Product temporarily on backorder. Additional lots will be available in the February 2027 timeframe. | Posted Nov 6, 2017 Updated Oct 14, 2026 |
| Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9254-25) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Demand increase for the drug | Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released. | Posted Nov 6, 2017 Updated Sep 18, 2026 |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-0042-12) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Nov 6, 2017 Updated Oct 8, 2026 | |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-1858-12) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Nov 6, 2017 Updated Oct 8, 2026 | |
| Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Nov 6, 2017 Updated Oct 8, 2026 | |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24) | Hospira, Inc., a Pfizer Company | Current Unavailable |
Other | Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay | Posted Nov 6, 2017 Updated Oct 8, 2026 |
| Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (NDC 0409-9104-20) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Nov 6, 2017 Updated Oct 8, 2026 |